Repurposing of ribavirin as an adjunct therapy against invasive Candida strains: In vitro study

Hanane Yousfi; Carole Cassagne; Stephane Ranque; Jean-Marc Rolain; Fadi Bittar

doi:10.1128/AAC.00263-19

Journal articles

Repurposing of ribavirin as an adjunct therapy against invasive Candida strains: In vitro study

Hanane Yousfi Carole Cassagne ¹ Stephane Ranque ¹ Jean-Marc Rolain ² Fadi Bittar ²

1 VITROME - Vecteurs - Infections tropicales et méditerranéennes

2 MEPHI - Microbes évolution phylogénie et infections

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Microbiology and Parasitology / Bacteriology

Life Sciences [q-bio] / Microbiology and Parasitology / Virology

Life Sciences [q-bio] / Microbiology and Parasitology / Parasitology

Life Sciences [q-bio] / Human health and pathology / Cardiology and cardiovascular system

Life Sciences [q-bio] / Human health and pathology / Emerging diseases

Life Sciences [q-bio] / Human health and pathology / Infectious diseases

Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-02263610
Contributor : Isabelle Combe <>
Submitted on : Monday, August 5, 2019 - 12:37:32 PM
Last modification on : Tuesday, August 6, 2019 - 1:16:14 AM

Repurposing of ribavirin as an adjunct therapy against invasive Candida strains: In vitro study

Links full text

Identifiers

Collections

Citation

Export

Metrics

42

Repurposing of ribavirin as an adjunct therapy against invasive Candida strains: In vitro study

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

42